27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Friday, Goldman Sachs analyst Matthew J. Fassler reiterated a Neutral rating on Rite Aid (NYSE: RAD), and raised the price target from $2.60 to $2.90.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
In the report, Goldman Sachs noted, “RAD reported first quarter results that were in line with guidance issued earlier this month and took pains to map out the strongly front-loaded nature of the year on its conference call. While we were well aware of 2H13 deceleration – and the company spelled out gross margin declines in guidance released just two weeks ago – we do not believe investors fully appreciated the magnitude of the shift in trend. We continue to see long-term appeal in the RAD story, but remain Neutral rated on what we consider to be a tough setup for the stock, which has had a big run versus the market, aided by better operating results and opportunistic financings.”
Rite Aid closed on Thursday at $2.88.